1. Explain the structure and functions of mitochondria. Enumerate common mitochondrial disorders and mention their key clinical features. 2. Explain the structure and functions of lysosomes. Add a note on lysosomal storage disorders. 3. Describe the fluid mosaic model of biological membranes. Add a labelled diagram. 4. Classify membrane transport mechanisms. Describe any two with examples. 5. Define carbohydrates. Classify with suitable examples. Add a note on glycosaminoglycans. 6. Classify amino acids on the basis of nutritional and metabolic significance. Add a note on functions of biologically important peptides. 7. Define proteins. Write in detail structural organization of proteins. Add a note on disorders associated with misfolded proteins. 8. Describe the functions of plasma proteins. Add a note on clinical significance of acute phase proteins. 9. Describe the structure of immunoglobulin. Classify immunoglobulins along with their functions. Explain paraproteinemias in brief. 10. Define lipids. Classify with suitable examples. Add a note on functions and clinical significance of phospholipids. 11. Define nucleotide and nucleoside. Outline and describe the structural features of DNA double helix. Add a note on clinical applications of synthetic nucleotide analogs. 12. Compare the structural features of different conformations of DNA double helix. Add a note on functions of biologically important nucleotides. 13. Describe the types, structure and functions of RNA. 14. Define enzymes. Classify with suitable examples. Add a note on mechanisms of enzyme action. 15. Define enzymes. Explain in detail factors affecting enzyme activity. 16. What is enzyme inhibitor? Give detail account of types of enzyme inhibitions with their clinical significance. 17. Write in detail diagnostic and therapeutic importance of enzymes. 1 | P a g e 18. Define isoenzymes. Give detail account of isoenzymes of Lactate dehydrogenase including their clinical significance. 19. Explain in detail biochemical functions and deficiency manifestations of vitamin A. 20. Explain in detail biochemical functions and deficiency manifestations of vitamin D. 21. Explain in detail biochemical functions and deficiency manifestations of vitamin K. 22. Describe biochemical functions and deficiency manifestations of vitamin C. 23. Explain in detail biochemical functions and deficiency manifestations of niacin. 24. Explain in detail biochemical functions and deficiency manifestations of hematopoietic vitamins. 25. Outline and explain the components of electron transport chain in detail. Add a note on inhibitors of ETC. 26. What is oxidative phosphorylation? Describe the mechanisms of oxidative phosphorylation. Add a note on inhibitors and inherited disorders of oxidative phosphorylation. 27. Define free radical. Describe the role of oxidative stress in pathogenesis of various diseases. 28. What are antioxidants. Classify antioxidants with suitable examples and enumerate their functions. 29. Describe the steps of aerobic glycolysis. Add a note on its energetics, regulation and inhibitors. 30. Describe steps in Rapaport-Leubering cycle. Add a note on significance of 2,3- BPG. 31. Describe the steps of Krebs cycle. Add a note on its energetics, regulation and inhibitors. 32. Describe the pathway of gluconeogenesis. Add a note on its precursors and regulation. 33. Describe the steps in HMP shunt pathway. Add a note on significance of this pathway and associated disorders. 34. Describe the steps in glycogen metabolism. Add a note on glycogen storage disorders. 2 | P a g e 35. Describe in detail glycogen metabolism. Add a note on its hormonal regulation. 36. Discuss the various mechanisms and role of hormones in blood glucose regulation. Add a note on types of diabetes mellitus. 37. Describe the oral glucose tolerance test including its procedure, indication, contraindication and interpretation. Add a note on types of GTT. 38. Describe the metabolic derangements in diabetes mellitus. Add a note on acute and chronic complications of diabetes mellitus and biochemical indices of diabetic control. 39. Write in detail metabolic processes in specific organs in fasting and fed state. 40. Describe the structure, functions and metabolism of lipoproteins. Add a note on atherosclerosis. 41. Describe in detail the stages in β-oxidation of fatty acids. Add a note on its energetics and associated disorders. 42. Explain in detail the synthesis and utilization of ketone bodies. Add a note on ketosis in starvation and diabetes mellitus. 43. Describe the synthesis and degradation of triacylglycerol along with its hormonal regulation. Add a note on metabolic derangements in fatty liver along with responsible factors. 44. Describe the steps in the biosynthesis of cholesterol along with its regulation. Add a note on hypercholesterolemia and hypocholesterolemia. 45. Describe the steps in the degradation of cholesterol. Add a note on cholelithiasis. 46. Describe the metabolic derangements in obesity and explain their role in the development of metabolic syndrome. 47. What are eicosanoids? Explain the biochemical functions and therapeutic applications of eicosanoids and their inhibitors. 48. Describe formation and transport of ammonia and explain role of transamination and deamination in the ammonia formation. 49. Give detail account of urea cycle. Add a note on its regulation and associated disorders. 50. Describe the metabolism of glycine. Add a note on metabolic disorders of glycine. 51. Describe the steps in the synthesis of creatine and glutathione. Explain their biochemical functions and clinical significance. 3 | P a g e 52. Describe the steps in the degradation of phenylalanine and tyrosine. Add a note on associated inborn errors of metabolism. 53. Discuss in detail metabolic disorders of phenyl alanine and tyrosine. 54. Describe the steps in the synthesis of melanin, thyroxine and catecholamines from tyrosine. Add a note on associated disorders. 55. Write in detail the steps in serotonin and kynurenine pathways of tryptophan metabolism. Add a note on Hartnup’s disease. 56. Give detailed account of one carbon metabolism/fate of carbon skeleton of amino acids. 57. Describe the metabolic pathways for methionine and cysteine. Add a note on inborn errors associated with their metabolism. 58. Write in brief various inborn errors of amino acid metabolism. 59. Describe the steps in the degradation of branched chain amino acids. Explain metabolic defects associated with their metabolism. 60. Describe the synthesis, functions and mechanism of action of nitric oxide. 61. Describe the structure and functions of hemoglobin. Write a note on abnormal hemoglobins. 62. Describe molecular basis of sickle cell anemia along with associated abnormalities and mechanism of sickling. Add a note on suggested diagnostic tests and management of the disease. 63. What are thalassemias? Describe its molecular basis. Explain α-thalassemias and β-thalassemias in detail. 64. Write in detail steps in the synthesis of heme. Add a note on porphyrias. 65. Give detail account of degradation of heme. Add a note on types of jaundice. 66. Outline the metabolism of heme. Classify and explain hereditary hyperbilirubinemias. 67. Describe the steps in the de novo biosynthesis of purine nucleotides. Explain the clinical applications of inhibitors of purine synthesis. 68. Write the steps in salvage pathway of purine nucleotide synthesis. Describe in detail Lesch-Nyhan syndrome. 69. Write the steps in the catabolism of purine nucleotides. Add a note on primary and secondary gout. 4 | P a g e 70. Describe the synthesis and degradation of pyrimidines and disorders associated with them. 71. Describe the dietary sources, absorption, transport, metabolism, biochemical functions and deficiency manifestations of iron and copper. 72. Describe the dietary sources and absorption of calcium and phosphorus. Explain plasma calcium homeostasis. Add a note on associated diseases. 73. Describe the dietary sources of magnesium and zinc. Explain their biochemical functions and deficiency manifestations. 74. Define detoxification. Describe the mechanisms of detoxification. Write in detail metabolism of xenobiotics. 75. Define balanced diet. Write in detail different food groups and example of balanced diet. Provide dietary advice for optimal health in coronary artery disease and diabetes mellitus. 76. Compare and contrast Kwashiorkar and Marasmus. 77. Explain the regulation of water and electrolyte balance. Add a note on dehydration. 78. Describe in detail the three mechanisms involved in maintenance of blood pH. 79. Write in detail renal regulation of acid-base balance. Add a note on metabolic acidosis. 80. Give detailed account of acid-base disorders. 81. Write four functions of kidney. Describe in detail tests done in clinical practice to assess kidney function. 82. Write four functions of liver. Describe in detail tests done in clinical practice to assess liver function. 83. Write functions of thyroid gland. Give detailed account of thyroid function tests. 84. Write functions of adrenal gland. Give detailed account of adrenal function tests. 85. Describe the process of replication in prokaryotes and eukaryotes. Add a note on inhibitors of DNA replication. 86. Describe in detail mechanisms of DNA repair. Add a note on disorders associated with defects in DNA repair. 87. What is mutation in DNA? Describe different types and consequences of DNA mutations. 5 | P a g e 88. Describe in detail process of transcription. Compare transcription in prokaryotes and eukaryotes. Add a note on post-transcriptional modifications. 89. Outline the initiation, elongation and termination in protein biosynthesis. Explain in detail post-translational modifications. 90. Discuss in detail inhibitors of transcription and translation. 91. Describe in detail Lac operon. 92. Explain the regulation of gene expression in eukaryotes. 93. Outline the basic principle of rDNA technology. Describe in detail applications of recombinant DNA technology. 94. Write in brief principle of PCR. Add a note on applications of PCR. 95. Outline the principles of FISH, microarray and CRISPR and write their applications. 96. Explain the biochemical changes in AIDS. 97. Define cancer. Write in detail mechanisms of oncogene activation. 98. What are tumor markers. Write in detail clinical significance of various tumor markers. 99. Describe in detail biochemical basis of cancer therapies. 100. Explain the roles of artificial intelligence in clinical laboratory practices. Can you please give me detailed answer of all these hundred questions with exam-oriented in MBBS exam and with colorful diagrams and well-labeled flowcharts and full diagram pics colorful.
Asking for Preferences
Reading File
Running Command
mkdir -p /home/daytona/workspace/biochem-notes && echo "Directory ready"
Writing File
~/biochem-notes/generate_part1.py
# Part 1: HTML header + Questions 1-25
content = '''<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8"/>
<meta name="viewport" content="width=device-width, initial-scale=1.0"/>
<title>MBBS Biochemistry - 100 Questions Detailed Answers</title>
<style>
@import url('https://fonts.googleapis.com/css2?family=Roboto:wght@300;400;700&family=Roboto+Slab:wght@400;700&display=swap');
* { box-sizing: border-box; margin: 0; padding: 0; }
body {
font-family: 'Roboto', Arial, sans-serif;
font-size: 13px;
line-height: 1.7;
color: #1a1a2e;
background: #f8f9ff;
}
.cover {
background: linear-gradient(135deg, #1a1a2e 0%, #16213e 40%, #0f3460 70%, #533483 100%);
color: white;
text-align: center;
padding: 100px 40px;
min-height: 100vh;
display: flex;
flex-direction: column;
justify-content: center;
align-items: center;
page-break-after: always;
}
.cover h1 {
font-size: 42px;
font-family: 'Roboto Slab', serif;
margin-bottom: 20px;
text-shadow: 2px 2px 8px rgba(0,0,0,0.5);
color: #e2b96f;
}
.cover h2 {
font-size: 26px;
margin-bottom: 30px;
color: #a8d8ea;
}
.cover .subtitle {
font-size: 18px;
color: #d4e6f1;
margin-bottom: 15px;
max-width: 600px;
}
.cover .badge {
background: #e2b96f;
color: #1a1a2e;
padding: 8px 24px;
border-radius: 30px;
font-weight: 700;
font-size: 16px;
margin-top: 20px;
display: inline-block;
}
.cover .dna-art {
font-size: 60px;
margin: 20px 0;
animation: none;
}
.toc {
page-break-after: always;
padding: 40px;
background: white;
}
.toc h2 {
font-size: 28px;
color: #1a1a2e;
border-bottom: 4px solid #0f3460;
padding-bottom: 12px;
margin-bottom: 24px;
font-family: 'Roboto Slab', serif;
}
.toc-section {
margin-bottom: 20px;
}
.toc-section h3 {
font-size: 15px;
color: #0f3460;
font-weight: 700;
margin-bottom: 8px;
padding: 6px 12px;
background: #e8f0fe;
border-radius: 4px;
}
.toc-item {
display: flex;
justify-content: space-between;
padding: 3px 12px;
font-size: 12px;
color: #444;
border-bottom: 1px dotted #ddd;
}
.toc-item span:first-child {
color: #0f3460;
font-weight: 500;
}
.page-section {
padding: 30px 40px;
background: white;
margin: 0;
}
.question-block {
page-break-before: always;
padding: 30px 40px;
background: white;
}
.question-block:first-of-type {
page-break-before: auto;
}
.q-header {
background: linear-gradient(135deg, #1a1a2e, #0f3460);
color: white;
padding: 18px 24px;
border-radius: 10px 10px 0 0;
margin-bottom: 0;
display: flex;
align-items: center;
gap: 16px;
}
.q-number {
background: #e2b96f;
color: #1a1a2e;
font-size: 18px;
font-weight: 900;
width: 46px;
height: 46px;
border-radius: 50%;
display: flex;
align-items: center;
justify-content: center;
flex-shrink: 0;
font-family: 'Roboto Slab', serif;
}
.q-title {
font-size: 17px;
font-weight: 700;
color: #e2b96f;
font-family: 'Roboto Slab', serif;
line-height: 1.4;
}
.q-body {
background: white;
border: 1px solid #e0e7ff;
border-top: none;
border-radius: 0 0 10px 10px;
padding: 24px 28px;
box-shadow: 0 4px 15px rgba(0,0,0,0.07);
}
h2.section-title {
font-size: 16px;
color: #0f3460;
font-family: 'Roboto Slab', serif;
border-left: 5px solid #e2b96f;
padding: 6px 12px;
margin: 18px 0 10px 0;
background: #f0f4ff;
border-radius: 0 6px 6px 0;
}
h3.sub-title {
font-size: 14px;
color: #16213e;
font-weight: 700;
margin: 14px 0 8px 0;
padding-left: 10px;
border-left: 3px solid #533483;
}
p {
margin: 8px 0;
text-align: justify;
}
ul, ol {
margin: 8px 0 8px 24px;
}
li {
margin: 4px 0;
}
.highlight-box {
background: linear-gradient(135deg, #fff9e6, #fff3cd);
border: 2px solid #e2b96f;
border-radius: 8px;
padding: 14px 18px;
margin: 14px 0;
}
.highlight-box .box-title {
font-weight: 700;
color: #7d5a00;
font-size: 13px;
margin-bottom: 6px;
text-transform: uppercase;
letter-spacing: 0.5px;
}
.clinical-box {
background: linear-gradient(135deg, #e8f8f5, #d5f5e3);
border: 2px solid #27ae60;
border-radius: 8px;
padding: 14px 18px;
margin: 14px 0;
}
.clinical-box .box-title {
font-weight: 700;
color: #1a5e37;
font-size: 13px;
margin-bottom: 6px;
text-transform: uppercase;
}
.warning-box {
background: linear-gradient(135deg, #fef9f0, #fdebd0);
border: 2px solid #e67e22;
border-radius: 8px;
padding: 14px 18px;
margin: 14px 0;
}
.warning-box .box-title {
font-weight: 700;
color: #935116;
font-size: 13px;
margin-bottom: 6px;
text-transform: uppercase;
}
.info-box {
background: linear-gradient(135deg, #eaf2ff, #d6e9ff);
border: 2px solid #2980b9;
border-radius: 8px;
padding: 14px 18px;
margin: 14px 0;
}
.info-box .box-title {
font-weight: 700;
color: #1a5276;
font-size: 13px;
margin-bottom: 6px;
text-transform: uppercase;
}
.diagram {
background: #f8f9ff;
border: 2px solid #0f3460;
border-radius: 10px;
padding: 20px;
margin: 18px 0;
text-align: center;
font-family: 'Courier New', monospace;
font-size: 11px;
}
.diagram .diagram-title {
font-family: 'Roboto Slab', serif;
font-size: 14px;
font-weight: 700;
color: #0f3460;
margin-bottom: 14px;
text-transform: uppercase;
letter-spacing: 0.5px;
}
.flowchart {
display: flex;
flex-direction: column;
align-items: center;
gap: 2px;
margin: 14px 0;
}
.flow-box {
background: linear-gradient(135deg, #0f3460, #1a5276);
color: white;
padding: 8px 20px;
border-radius: 6px;
font-weight: 700;
font-size: 12px;
text-align: center;
min-width: 200px;
max-width: 400px;
box-shadow: 0 2px 8px rgba(0,0,0,0.2);
}
.flow-box.green {
background: linear-gradient(135deg, #1e8449, #27ae60);
}
.flow-box.orange {
background: linear-gradient(135deg, #ca6f1e, #e67e22);
}
.flow-box.purple {
background: linear-gradient(135deg, #6c3483, #8e44ad);
}
.flow-box.red {
background: linear-gradient(135deg, #922b21, #c0392b);
}
.flow-box.teal {
background: linear-gradient(135deg, #148f77, #1abc9c);
}
.flow-box.gold {
background: #8d6e00;
color: white;
}
.flow-box.light {
background: white;
color: #1a1a2e;
border: 2px solid #0f3460;
}
.flow-arrow {
font-size: 20px;
color: #0f3460;
font-weight: 700;
margin: 1px 0;
}
.flow-row {
display: flex;
align-items: center;
gap: 10px;
justify-content: center;
flex-wrap: wrap;
}
.flow-horiz-arrow {
font-size: 18px;
color: #0f3460;
font-weight: 700;
}
table {
width: 100%;
border-collapse: collapse;
margin: 14px 0;
font-size: 12px;
box-shadow: 0 2px 10px rgba(0,0,0,0.08);
border-radius: 8px;
overflow: hidden;
}
th {
background: linear-gradient(135deg, #0f3460, #1a5276);
color: white;
padding: 10px 12px;
text-align: left;
font-size: 12px;
font-weight: 700;
letter-spacing: 0.3px;
}
td {
padding: 8px 12px;
border-bottom: 1px solid #e8f0ff;
vertical-align: top;
}
tr:nth-child(even) td {
background: #f0f4ff;
}
tr:nth-child(odd) td {
background: white;
}
tr:hover td {
background: #e8f0ff;
}
.mnemonic {
background: linear-gradient(135deg, #f4ecff, #e8d8ff);
border: 2px solid #8e44ad;
border-radius: 8px;
padding: 12px 16px;
margin: 12px 0;
font-weight: 700;
color: #4a235a;
}
.mnemonic::before {
content: "🧠 MNEMONIC: ";
color: #6c3483;
}
.key-point {
background: linear-gradient(90deg, #e2b96f, #f0d090);
padding: 2px 8px;
border-radius: 4px;
font-weight: 700;
color: #5d4000;
font-size: 11px;
}
.structure-diagram {
background: white;
border: 2px dashed #0f3460;
border-radius: 10px;
padding: 20px;
margin: 16px 0;
font-family: 'Courier New', monospace;
font-size: 10px;
line-height: 1.5;
position: relative;
}
.structure-diagram .diagram-label {
position: absolute;
background: #0f3460;
color: white;
padding: 3px 10px;
border-radius: 0 0 8px 0;
top: 0;
left: 0;
font-size: 10px;
font-weight: 700;
letter-spacing: 0.5px;
font-family: 'Roboto', sans-serif;
}
.organ-box {
display: inline-block;
background: linear-gradient(135deg, #1e8449, #27ae60);
color: white;
border-radius: 50%;
width: 100px;
height: 100px;
line-height: 100px;
text-align: center;
font-weight: 700;
font-size: 12px;
margin: 5px;
box-shadow: 0 4px 12px rgba(39,174,96,0.4);
}
.energy-badge {
background: linear-gradient(135deg, #e67e22, #f39c12);
color: white;
padding: 4px 12px;
border-radius: 20px;
font-weight: 700;
font-size: 12px;
display: inline-block;
margin: 3px;
}
@media print {
.question-block {
page-break-before: always;
}
.question-block:first-of-type {
page-break-before: auto;
}
}
.chapter-divider {
page-break-before: always;
background: linear-gradient(135deg, #1a1a2e, #0f3460);
color: white;
padding: 60px 40px;
text-align: center;
margin: 0;
}
.chapter-divider h2 {
font-size: 32px;
font-family: 'Roboto Slab', serif;
color: #e2b96f;
margin-bottom: 12px;
}
.chapter-divider p {
color: #a8d8ea;
font-size: 16px;
text-align: center;
}
.dna-strand {
font-size: 24px;
letter-spacing: 2px;
color: #e2b96f;
margin: 20px 0;
}
.two-col {
display: grid;
grid-template-columns: 1fr 1fr;
gap: 16px;
margin: 14px 0;
}
.col-box {
background: #f8f9ff;
border: 1px solid #e0e7ff;
border-radius: 8px;
padding: 14px;
}
.col-box h4 {
color: #0f3460;
font-size: 13px;
margin-bottom: 8px;
border-bottom: 2px solid #e2b96f;
padding-bottom: 4px;
}
.step-list {
counter-reset: step-counter;
list-style: none;
padding: 0;
margin: 10px 0;
}
.step-list li {
counter-increment: step-counter;
padding: 6px 10px 6px 40px;
position: relative;
border-bottom: 1px dashed #e0e7ff;
margin: 4px 0;
}
.step-list li::before {
content: counter(step-counter);
position: absolute;
left: 6px;
top: 50%;
transform: translateY(-50%);
background: #0f3460;
color: white;
width: 24px;
height: 24px;
border-radius: 50%;
display: flex;
align-items: center;
justify-content: center;
font-size: 11px;
font-weight: 700;
}
.molecule-art {
background: #f0f8ff;
border-radius: 10px;
padding: 15px;
text-align: center;
font-family: 'Courier New', monospace;
font-size: 11px;
line-height: 1.8;
color: #1a1a2e;
margin: 12px 0;
}
</style>
</head>
<body>
<!-- COVER PAGE -->
<div class="cover">
<div class="dna-art">🧬</div>
<h1>Biochemistry</h1>
<h2>MBBS Examination Guide</h2>
<p class="subtitle">100 Most Important Questions — Detailed Exam-Oriented Answers</p>
<p class="subtitle">With Diagrams, Flowcharts, Tables & Clinical Correlations</p>
<div class="badge">Full Syllabus Coverage — MBBS Phase I & II</div>
<br/>
<div style="color:#aaa; font-size:13px; margin-top:30px;">
Covering: Cell Biology • Biomolecules • Metabolism • Molecular Biology • Clinical Biochemistry
</div>
</div>
<!-- TABLE OF CONTENTS -->
<div class="toc">
<h2>Table of Contents</h2>
<div class="toc-section">
<h3>UNIT 1: Cell Biology & Biomembranes (Q 1-4)</h3>
<div class="toc-item"><span>Q1. Mitochondria: Structure, Functions & Disorders</span><span>3</span></div>
<div class="toc-item"><span>Q2. Lysosomes: Structure, Functions & Storage Disorders</span><span>5</span></div>
<div class="toc-item"><span>Q3. Fluid Mosaic Model of Biological Membranes</span><span>7</span></div>
<div class="toc-item"><span>Q4. Membrane Transport Mechanisms</span><span>9</span></div>
</div>
<div class="toc-section">
<h3>UNIT 2: Biomolecules (Q 5-13)</h3>
<div class="toc-item"><span>Q5. Carbohydrates: Classification & Glycosaminoglycans</span><span>11</span></div>
<div class="toc-item"><span>Q6. Amino Acids: Classification by Nutritional & Metabolic Significance</span><span>13</span></div>
<div class="toc-item"><span>Q7. Proteins: Structure & Misfolding Disorders</span><span>15</span></div>
<div class="toc-item"><span>Q8. Plasma Proteins & Acute Phase Proteins</span><span>17</span></div>
<div class="toc-item"><span>Q9. Immunoglobulins: Structure, Classification & Paraproteinemias</span><span>19</span></div>
<div class="toc-item"><span>Q10. Lipids: Classification & Phospholipids</span><span>21</span></div>
<div class="toc-item"><span>Q11. Nucleotides, DNA Double Helix & Synthetic Analogs</span><span>23</span></div>
<div class="toc-item"><span>Q12. DNA Conformations & Biologically Important Nucleotides</span><span>25</span></div>
<div class="toc-item"><span>Q13. Types, Structure & Functions of RNA</span><span>27</span></div>
</div>
<div class="toc-section">
<h3>UNIT 3: Enzymology (Q 14-18)</h3>
<div class="toc-item"><span>Q14. Enzymes: Classification & Mechanisms of Action</span><span>29</span></div>
<div class="toc-item"><span>Q15. Factors Affecting Enzyme Activity</span><span>31</span></div>
<div class="toc-item"><span>Q16. Enzyme Inhibitors & Types of Inhibition</span><span>33</span></div>
<div class="toc-item"><span>Q17. Diagnostic & Therapeutic Importance of Enzymes</span><span>35</span></div>
<div class="toc-item"><span>Q18. Isoenzymes of LDH & Clinical Significance</span><span>37</span></div>
</div>
<div class="toc-section">
<h3>UNIT 4: Vitamins (Q 19-24)</h3>
<div class="toc-item"><span>Q19-24. Fat-Soluble & Water-Soluble Vitamins (A, D, K, C, Niacin, Hematopoietic)</span><span>39</span></div>
</div>
<div class="toc-section">
<h3>UNIT 5: Bioenergetics (Q 25-28)</h3>
<div class="toc-item"><span>Q25. Electron Transport Chain & Its Inhibitors</span><span>49</span></div>
<div class="toc-item"><span>Q26. Oxidative Phosphorylation</span><span>51</span></div>
<div class="toc-item"><span>Q27-28. Free Radicals, Oxidative Stress & Antioxidants</span><span>53</span></div>
</div>
<div class="toc-section">
<h3>UNIT 6: Carbohydrate Metabolism (Q 29-38)</h3>
<div class="toc-item"><span>Q29-38. Glycolysis, Krebs Cycle, Gluconeogenesis, HMP, Glycogen, Diabetes</span><span>56</span></div>
</div>
<div class="toc-section">
<h3>UNIT 7: Lipid Metabolism (Q 40-47)</h3>
<div class="toc-item"><span>Q40-47. Lipoproteins, β-oxidation, Ketone Bodies, Cholesterol, Eicosanoids</span><span>76</span></div>
</div>
<div class="toc-section">
<h3>UNIT 8: Protein & Amino Acid Metabolism (Q 48-60)</h3>
<div class="toc-item"><span>Q48-60. Urea Cycle, Amino Acid Pathways, Inborn Errors, Nitric Oxide</span><span>94</span></div>
</div>
<div class="toc-section">
<h3>UNIT 9: Hemoglobin & Porphyrins (Q 61-66)</h3>
<div class="toc-item"><span>Q61-66. Hemoglobin, Sickle Cell, Thalassemia, Heme Synthesis, Jaundice</span><span>116</span></div>
</div>
<div class="toc-section">
<h3>UNIT 10: Nucleotide Metabolism (Q 67-70)</h3>
<div class="toc-item"><span>Q67-70. Purine & Pyrimidine Synthesis, Catabolism, Gout, Lesch-Nyhan</span><span>128</span></div>
</div>
<div class="toc-section">
<h3>UNIT 11: Minerals & Special Topics (Q 71-84)</h3>
<div class="toc-item"><span>Q71-84. Minerals, Acid-Base, Kidney/Liver/Thyroid/Adrenal Function Tests</span><span>136</span></div>
</div>
<div class="toc-section">
<h3>UNIT 12: Molecular Biology (Q 85-100)</h3>
<div class="toc-item"><span>Q85-100. DNA Replication, Repair, Transcription, Translation, Lac Operon, rDNA, Cancer</span><span>158</span></div>
</div>
</div>
<!-- ===================== QUESTION 1 ===================== -->
<div class="question-block">
<div class="q-header">
<div class="q-number">1</div>
<div class="q-title">Explain the structure and functions of mitochondria. Enumerate common mitochondrial disorders and mention their key clinical features.</div>
</div>
<div class="q-body">
<h2 class="section-title">Introduction</h2>
<p>Mitochondria are membrane-bound organelles present in virtually all eukaryotic cells except mature red blood cells. They are the primary sites of cellular energy production and are often called the <strong>"powerhouses of the cell"</strong>. Each cell may contain 1-2000+ mitochondria depending on metabolic demands. They possess their own DNA (mtDNA) and reproduce by binary fission.</p>
<h2 class="section-title">Structure of Mitochondria</h2>
<div class="diagram">
<div class="diagram-title">🔬 Structure of Mitochondrion (Cross-Section)</div>
<pre style="font-size:10px; line-height:1.6; color:#1a1a2e; text-align:left; display:inline-block;">
┌─────────────────────────────────────────────────────────────────┐
│ OUTER MITOCHONDRIAL MEMBRANE (OMM) │
│ [Contains: Porins/VDAC, Monoamine oxidase, Porin channels] │
│ ┌───────────────────────────────────────────────────────────┐ │
│ │ INTERMEMBRANE SPACE (IMS) │ │
│ │ [Cytochrome c, ATP synthase subunits, Adenylate kinase] │ │
│ │ ┌─────────────────────────────────────────────────────┐ │ │
│ │ │ INNER MITOCHONDRIAL MEMBRANE (IMM) │ │ │
│ │ │ ┌───────┐ ┌───────┐ ┌───────┐ ┌───────┐ │ │ │
│ │ │ │Crista │ │Crista │ │Crista │ │Crista │ │ │ │
│ │ │ │ │ │ │ │ │ │ │ │ │ │
│ │ │ └───────┘ └───────┘ └───────┘ └───────┘ │ │ │
│ │ │ [ETC complexes I-IV, ATP synthase (Complex V), │ │ │
│ │ │ Cardiolipin, Carriers: ANT, Pi carrier] │ │ │
│ │ │ ┌─────────────────────────────────────────────┐ │ │ │
│ │ │ │ MATRIX │ │ │ │
│ │ │ │ [Krebs cycle enzymes, Pyruvate dehydrogenase│ │ │ │
│ │ │ │ β-oxidation enzymes, mtDNA, Ribosomes, │ │ │ │
│ │ │ │ tRNA, rRNA, mtRNA polymerase, Malate │ │ │ │
│ │ │ │ dehydrogenase, Glutamate dehydrogenase] │ │ │ │
│ │ │ └─────────────────────────────────────────────┘ │ │ │
│ │ └─────────────────────────────────────────────────────┘ │ │
│ └───────────────────────────────────────────────────────────┘ │
└─────────────────────────────────────────────────────────────────┘</pre>
</div>
<h3 class="sub-title">A. Outer Mitochondrial Membrane (OMM)</h3>
<ul>
<li>Smooth, continuous membrane surrounding the entire organelle</li>
<li>Contains <strong>Porins (VDAC - Voltage-Dependent Anion Channels)</strong> - allow free passage of molecules <5 kDa</li>
<li>Contains enzymes: monoamine oxidase (MAO), fatty acyl CoA synthetase, glycerophosphate acyltransferase</li>
<li>Lipid:Protein ratio = 1:1</li>
</ul>
<h3 class="sub-title">B. Intermembrane Space (IMS)</h3>
<ul>
<li>Space between OMM and IMM</li>
<li>Contains: <strong>Cytochrome c</strong> (key player in apoptosis), adenylate kinase, creatine kinase</li>
<li>pH is lower than matrix due to proton pumping</li>
<li>Critical for apoptosis signaling - cytochrome c release triggers caspase cascade</li>
</ul>
<h3 class="sub-title">C. Inner Mitochondrial Membrane (IMM)</h3>
<ul>
<li>Highly folded into <strong>cristae</strong> (increases surface area up to 5x)</li>
<li>Rich in cardiolipin (diphosphatidylglycerol) - maintains impermeability and ETC function</li>
<li>Contains ETC complexes I, II, III, IV and ATP synthase (Complex V)</li>
<li><strong>Impermeable</strong> to H⁺, Na⁺, K⁺, Cl⁻ - maintains proton gradient</li>
<li>Protein:Lipid ratio = 3:1 (highest protein content of any biological membrane)</li>
<li>Carriers: ANT (adenine nucleotide translocase), malate-aspartate shuttle components</li>
</ul>
<h3 class="sub-title">D. Matrix</h3>
<ul>
<li>Contains: TCA cycle enzymes, pyruvate dehydrogenase complex, β-oxidation enzymes</li>
<li><strong>mtDNA</strong>: circular, double-stranded, 16,569 bp, encodes 13 proteins (all ETC subunits), 22 tRNAs, 2 rRNAs</li>
<li>70S ribosomes (similar to prokaryotes - supports endosymbiont theory)</li>
<li>Matrix has alkaline pH (~8.0) due to proton export</li>
</ul>
<div class="highlight-box">
<div class="box-title">Key Feature: mtDNA Inheritance</div>
<p>mtDNA is exclusively maternally inherited. All mitochondria in a fertilized egg come from the oocyte. This has important implications for mitochondrial disease genetics - affected mothers pass disease to ALL children; affected fathers pass to NONE.</p>
</div>
<h2 class="section-title">Functions of Mitochondria</h2>
<table>
<tr><th>Function</th><th>Details</th><th>Location in Mitochondria</th></tr>
<tr><td><strong>ATP Production (Aerobic)</strong></td><td>Main source: oxidative phosphorylation via ETC; 1 glucose → ~30-32 ATP</td><td>IMM (ETC + ATP synthase)</td></tr>
<tr><td><strong>Krebs Cycle / TCA</strong></td><td>Generates NADH, FADH₂ for ETC; also generates GTP, CO₂</td><td>Matrix</td></tr>
<tr><td><strong>β-Oxidation of Fatty Acids</strong></td><td>Long-chain FA oxidation via carnitine shuttle; main energy in fasting</td><td>Matrix</td></tr>
<tr><td><strong>Pyruvate Oxidation</strong></td><td>Pyruvate → Acetyl CoA via PDH complex</td><td>Matrix</td></tr>
<tr><td><strong>Amino Acid Catabolism</strong></td><td>Transamination, deamination; urea cycle (partial)</td><td>Matrix</td></tr>
<tr><td><strong>Ketone Body Synthesis</strong></td><td>Acetoacetate, β-hydroxybutyrate, acetone formation</td><td>Matrix (liver)</td></tr>
<tr><td><strong>Heme Synthesis</strong></td><td>Initial step: ALA synthase (succinyl CoA + glycine → ALA)</td><td>Matrix</td></tr>
<tr><td><strong>Steroid Synthesis</strong></td><td>Side-chain cleavage of cholesterol (CYP11A1)</td><td>IMM (adrenal)</td></tr>
<tr><td><strong>Calcium Homeostasis</strong></td><td>Acts as Ca²⁺ buffer; regulates cell signaling</td><td>Matrix / IMM</td></tr>
<tr><td><strong>Apoptosis Control</strong></td><td>Cytochrome c release → caspase activation → programmed cell death</td><td>IMS</td></tr>
<tr><td><strong>ROS Generation</strong></td><td>Superoxide from Complex I and III; regulated by SOD2</td><td>IMM / Matrix</td></tr>
<tr><td><strong>Thermogenesis</strong></td><td>UCP1 (thermogenin) in brown adipose tissue uncouples ETC</td><td>IMM</td></tr>
</table>
<h2 class="section-title">Common Mitochondrial Disorders</h2>
<div class="info-box">
<div class="box-title">Important Concept: Heteroplasmy</div>
<p>A cell may contain a mixture of normal and mutant mtDNA (heteroplasmy). Clinical features appear when mutant mtDNA exceeds a threshold (~60-90%). This explains variable expressivity in mitochondrial diseases.</p>
</div>
<table>
<tr><th>Disorder</th><th>Mutation / Defect</th><th>Key Clinical Features</th></tr>
<tr>
<td><strong>MELAS</strong><br/>(Mitochondrial Encephalomyopathy, Lactic Acidosis & Stroke-like episodes)</td>
<td>A3243G mutation in MT-TL1 (tRNA-Leu gene); Complex I deficiency</td>
<td>Stroke-like episodes before age 40, seizures, dementia, lactic acidosis, ragged-red fibers on muscle biopsy, short stature, sensorineural deafness, diabetes mellitus</td>
</tr>
<tr>
<td><strong>MERRF</strong><br/>(Myoclonic Epilepsy with Ragged-Red Fibers)</td>
<td>A8344G mutation in MT-TK (tRNA-Lys); Complex I & IV deficiency</td>
<td>Myoclonic epilepsy, cerebellar ataxia, ragged-red fibers, dementia, sensorineural deafness, cardiac conduction defects</td>
</tr>
<tr>
<td><strong>LHON</strong><br/>(Leber Hereditary Optic Neuropathy)</td>
<td>G11778A, G3460A, T14484C in ND genes (Complex I subunits)</td>
<td>Acute/subacute bilateral visual loss (20-30 yrs), central scotoma, color vision loss; predominantly males affected; cardiac arrhythmias</td>
</tr>
<tr>
<td><strong>Kearns-Sayre Syndrome (KSS)</strong></td>
<td>Large mtDNA deletion (1-8 kb); sporadic</td>
<td>Progressive external ophthalmoplegia (PEO), pigmentary retinopathy, onset <20 yrs, heart block, cerebellar ataxia, elevated CSF protein</td>
</tr>
<tr>
<td><strong>Pearson Syndrome</strong></td>
<td>Large mtDNA deletion (same as KSS)</td>
<td>Sideroblastic anemia, pancytopenia, exocrine pancreatic failure in infancy; survivors often develop KSS</td>
</tr>
<tr>
<td><strong>Leigh Syndrome</strong><br/>(Subacute Necrotizing Encephalomyelopathy)</td>
<td>Multiple mutations: mtDNA or nuclear DNA; Complex I, II, IV, V deficiency; PDH deficiency</td>
<td>Hypotonia, psychomotor regression, brainstem dysfunction, lactic acidosis, bilateral symmetric lesions on MRI (basal ganglia), onset in infancy; poor prognosis</td>
</tr>
<tr>
<td><strong>NARP</strong><br/>(Neuropathy, Ataxia, Retinitis Pigmentosa)</td>
<td>T8993G/C mutation in MT-ATP6 (ATP synthase subunit 6)</td>
<td>Peripheral neuropathy, cerebellar ataxia, retinitis pigmentosa, developmental delay; same gene as Leigh at high heteroplasmy</td>
</tr>
<tr>
<td><strong>Alpers Syndrome</strong></td>
<td>POLG (polymerase gamma) nuclear gene mutations; mtDNA depletion</td>
<td>Progressive neuronal degeneration, refractory seizures, liver failure; valproate contraindicated (precipitates liver failure)</td>
</tr>
<tr>
<td><strong>CPEO</strong><br/>(Chronic Progressive External Ophthalmoplegia)</td>
<td>Single mtDNA deletion; may have nuclear POLG mutations</td>
<td>Bilateral ptosis and external ophthalmoplegia; may progress to KSS</td>
</tr>
</table>
<div class="clinical-box">
<div class="box-title">Clinical Pearl: Ragged-Red Fibers (RRF)</div>
<p>On modified Gomori trichrome stain of muscle biopsy, mitochondria accumulate beneath the sarcolemma forming <strong>ragged-red fibers</strong> - a hallmark of mitochondrial myopathy. The red color represents subsarcolemmal mitochondrial proliferation. Seen in MELAS, MERRF, KSS, CPEO.</p>
</div>
<div class="mnemonic">MELAS: Mitochondria, Encephalopathy, Lactic Acidosis, Stroke-like episodes = MELS = Muscles Eat Lactic acid Slowly</div>
<div class="flowchart" style="text-align:left;">
<div class="diagram-title" style="text-align:center;">Approach to Mitochondrial Disease Diagnosis</div>
<div style="text-align:center;">
<div class="flow-box">Clinical Features: Exercise intolerance, multisystem involvement, maternal inheritance</div>
<div class="flow-arrow">↓</div>
<div class="flow-box green">Investigations: Serum lactate, pyruvate, lactate:pyruvate ratio (>20)</div>
<div class="flow-arrow">↓</div>
<div class="flow-box orange">Muscle Biopsy: Ragged-red fibers (Gomori trichrome), COX-negative fibers</div>
<div class="flow-arrow">↓</div>
<div class="flow-box purple">Electron microscopy: Abnormal mitochondria with paracrystalline inclusions</div>
<div class="flow-arrow">↓</div>
<div class="flow-box red">Genetic Testing: mtDNA sequencing, deletion analysis, nuclear gene panel</div>
</div>
</div>
</div>
</div>
<!-- ===================== QUESTION 2 ===================== -->
<div class="question-block">
<div class="q-header">
<div class="q-number">2</div>
<div class="q-title">Explain the structure and functions of lysosomes. Add a note on lysosomal storage disorders.</div>
</div>
<div class="q-body">
<h2 class="section-title">Introduction</h2>
<p>Lysosomes are membrane-bound organelles found in eukaryotic cells, first described by <strong>Christian de Duve (1955)</strong> who was awarded the Nobel Prize for this discovery. They are the cell's <strong>"recycling centers"</strong> containing over 60 hydrolytic enzymes (acid hydrolases) capable of degrading virtually all biological macromolecules. They maintain an acidic internal pH (~4.5-5.0) maintained by V-type H⁺-ATPase proton pumps.</p>
<h2 class="section-title">Structure of Lysosomes</h2>
<div class="diagram">
<div class="diagram-title">🔬 Lysosome Structure</div>
<pre style="font-size:10px; line-height:1.6; color:#1a1a2e; text-align:left; display:inline-block;">
┌─────────────────────────────────────────┐
│ LYSOSOMAL MEMBRANE │
V-ATPase ──────► │ [H⁺ pump maintaining pH 4.5-5.0] │
(proton pump) │ [LAMP-1, LAMP-2 (lysosomal proteins)] │
│ [NPC1 (cholesterol exporter)] │
│ [CFTR-like Cl⁻ channels] │
│ │
│ LYSOSOMAL LUMEN │
│ │
│ Acid Hydrolases (active at pH 4.5-5): │
│ • Acid phosphatase (marker enzyme) │
│ • Cathepsins B, D, H, L (proteases) │
│ • Acid lipase │
│ • Acid DNase, RNase │
│ • Glucocerebrosidase │
│ • Hexosaminidase A & B │
│ • Arylsulfatase A & B │
│ • α-Galactosidase A │
│ • β-Glucuronidase │
│ • α-Iduronidase │
└─────────────────────────────────────────┘
Marker Enzyme of Lysosomes: ACID PHOSPHATASE</pre>
</div>
<h3 class="sub-title">Types of Lysosomes</h3>
<table>
<tr><th>Type</th><th>Description</th><th>Contents</th></tr>
<tr><td><strong>Primary Lysosome</strong></td><td>Newly formed, has not yet fused; contains inactive enzymes</td><td>Acid hydrolases (inactive)</td></tr>
<tr><td><strong>Secondary Lysosome</strong></td><td>Formed by fusion of primary lysosome with phagosome/autophagosome; active digestion occurs</td><td>Partially digested material + active enzymes</td></tr>
<tr><td><strong>Residual Body</strong></td><td>Contains undigested material (lipofuscin pigments); increases with age</td><td>Undigestible material (lipofuscin)</td></tr>
<tr><td><strong>Autophagolysosome</strong></td><td>Formed by fusion with autophagosome; digests worn-out organelles</td><td>Organelle debris</td></tr>
</table>
<h3 class="sub-title">Lysosomal Enzyme Targeting</h3>
<div class="flowchart" style="text-align:center;">
<div class="flow-box">Synthesis of Lysosomal Enzymes on Rough ER</div>
<div class="flow-arrow">↓</div>
<div class="flow-box green">N-linked glycosylation in ER → Mannose-rich oligosaccharides</div>
<div class="flow-arrow">↓</div>
<div class="flow-box orange">Phosphorylation of Mannose → Mannose-6-Phosphate (M-6-P) in Golgi</div>
<div class="flow-arrow">↓</div>
<div class="flow-box purple">Recognition by M-6-P Receptor on trans-Golgi Network</div>
<div class="flow-arrow">↓</div>
<div class="flow-box red">Packaging into vesicles → Transport to Lysosomes</div>
<div class="flow-arrow">↓</div>
<div class="flow-box teal">Low pH dissociates enzyme from receptor → Active lysosomal hydrolase</div>
</div>
<div class="warning-box">
<div class="box-title">I-Cell Disease (Inclusion Cell Disease / Mucolipidosis Type II)</div>
<p>Deficiency of <strong>GlcNAc-1-phosphotransferase</strong> enzyme that adds M-6-P tag. All lysosomal enzymes are secreted extracellularly instead of being targeted to lysosomes. Result: lysosomes filled with undegraded material (inclusions). Features: coarse facies, gingival hyperplasia, restricted joint movement, corneal clouding, severe psychomotor retardation. Detected by elevated plasma levels of lysosomal enzymes.</p>
</div>
<h2 class="section-title">Functions of Lysosomes</h2>
<ol class="step-list">
<li><strong>Intracellular Digestion (Autophagy):</strong> Digestion of worn-out organelles (mitophagy, ER-phagy). Critical for cellular homeostasis and survival during starvation.</li>
<li><strong>Extracellular Digestion (Heterophagy):</strong> Digestion of phagocytosed foreign material (bacteria, debris). Key in neutrophils and macrophages for immune defense.</li>
<li><strong>Defense Against Pathogens:</strong> Macrophage lysosomes destroy engulfed bacteria via acid hydrolases. Failure → mycobacterial persistence (TB).</li>
<li><strong>Bone Resorption:</strong> Osteoclasts secrete lysosomal enzymes into bone resorption lacunae. Cathepsins K and D break down bone matrix. Deficiency of carbonic anhydrase II → osteopetrosis.</li>
<li><strong>Thyroid Hormone Release:</strong> Proteolytic cleavage of thyroglobulin by lysosomal proteases releases T3 and T4.</li>
<li><strong>Fertilization:</strong> Acrosome of sperm is a specialized lysosome; releases hyaluronidase and acrosin to penetrate ovum.</li>
<li><strong>Programmed Cell Death:</strong> Release of cathepsins and hydrolases during lysosomal membrane permeabilization (LMP) contributes to cell death.</li>
<li><strong>Recycling of Cell Components:</strong> Amino acids, sugars, lipid components recycled back to cytoplasm for reuse.</li>
</ol>
<h2 class="section-title">Lysosomal Storage Disorders (LSDs)</h2>
<p>LSDs are inherited metabolic diseases caused by deficiency of specific lysosomal enzymes or transport proteins, leading to accumulation of undegraded substrates. Most are <strong>autosomal recessive</strong> with a combined incidence of ~1:7,700 live births.</p>
<h3 class="sub-title">Classification of LSDs</h3>
<table>
<tr><th>Category</th><th>Disease</th><th>Deficient Enzyme</th><th>Stored Substrate</th><th>Key Features</th></tr>
<tr>
<td rowspan="4"><strong>Sphingolipidoses</strong></td>
<td>Gaucher disease (most common LSD)</td>
<td>β-Glucocerebrosidase (Glucosylceramidase)</td>
<td>Glucocerebroside</td>
<td>Hepatosplenomegaly, "crinkled tissue paper" macrophages, Erlenmeyer flask deformity of femur, bone pain; Type 1 (non-neuropathic), Type 2/3 (neuropathic)</td>
</tr>
<tr>
<td>Niemann-Pick (Types A&B)</td>
<td>Sphingomyelinase</td>
<td>Sphingomyelin</td>
<td>Hepatosplenomegaly, "foam cells", cherry-red spot (Type A), progressive neurodegeneration (Type A)</td>
</tr>
<tr>
<td>Tay-Sachs disease</td>
<td>Hexosaminidase A (α-subunit)</td>
<td>GM2 ganglioside</td>
<td>Cherry-red spot (macula), progressive neurodegeneration, blindness, onset 6 months; no hepatosplenomegaly; fatal by 4 yrs</td>
</tr>
<tr>
<td>Fabry disease</td>
<td>α-Galactosidase A</td>
<td>Globotriaosylceramide (Gb3)</td>
<td>X-linked; angiokeratomas, acroparesthesia, corneal opacity, renal failure, cardiomyopathy; only LSD with X-linked inheritance</td>
</tr>
<tr>
<td rowspan="3"><strong>Mucopolysaccharidoses (MPS)</strong></td>
<td>Hurler Syndrome (MPS I-H)</td>
<td>α-L-Iduronidase</td>
<td>Heparan sulfate, Dermatan sulfate</td>
<td>Gargoylism, hepatosplenomegaly, corneal clouding, coarse facies, severe intellectual disability, gibbus deformity; AR; Dermatan > Heparan</td>
</tr>
<tr>
<td>Hunter Syndrome (MPS II)</td>
<td>Iduronate-2-sulfatase</td>
<td>Heparan sulfate, Dermatan sulfate</td>
<td>Similar to Hurler but NO corneal clouding; X-linked recessive; milder course</td>
</tr>
<tr>
<td>Sanfilippo Syndrome (MPS III)</td>
<td>Various (4 subtypes A-D)</td>
<td>Heparan sulfate</td>
<td>Severe behavioral problems, intellectual disability, mild somatic features</td>
</tr>
<tr>
<td><strong>Glycogen Storage</strong></td>
<td>Pompe Disease (GSD Type II)</td>
<td>Acid maltase (α-1,4-glucosidase)</td>
<td>Glycogen</td>
<td>Infantile: cardiomegaly, hypotonia, respiratory failure (fatal <2 yrs); Adult: proximal myopathy, respiratory insufficiency; Enzyme replacement therapy available</td>
</tr>
<tr>
<td><strong>Mucolipidoses</strong></td>
<td>I-Cell Disease (ML II)</td>
<td>GlcNAc-1-phosphotransferase</td>
<td>Multiple substrates</td>
<td>All lysosomal enzymes misrouted extracellularly; inclusion bodies in fibroblasts; severe psychomotor retardation</td>
</tr>
<tr>
<td><strong>Lipidoses</strong></td>
<td>Krabbe Disease</td>
<td>Galactocerebrosidase</td>
<td>Galactocerebroside</td>
<td>Globoid cell leukodystrophy; globoid macrophages in brain; severe neurodegeneration; onset 3-6 months</td>
</tr>
</table>
<div class="clinical-box">
<div class="box-title">Treatment Advances in LSDs</div>
<ul>
<li><strong>Enzyme Replacement Therapy (ERT):</strong> Gaucher (Imiglucerase), Pompe (Alglucosidase alfa), Fabry (Agalsidase), MPS I (Laronidase)</li>
<li><strong>Substrate Reduction Therapy (SRT):</strong> Reduces substrate synthesis - Miglustat (Gaucher, Niemann-Pick C), Eliglustat (Gaucher)</li>
<li><strong>Bone Marrow Transplantation:</strong> Hurler syndrome - can arrest neurological progression if done early</li>
<li><strong>Chaperone Therapy:</strong> For missense mutations - migalastat for Fabry disease</li>
</ul>
</div>
<div class="mnemonic">Cherry-red spot: Tay-Sachs, Niemann-Pick, Farber disease, Sandhoff disease = "TaNFS" = "The Neuronal Foam Spots"</div>
</div>
</div>
<!-- ===================== QUESTION 3 ===================== -->
<div class="question-block">
<div class="q-header">
<div class="q-number">3</div>
<div class="q-title">Describe the fluid mosaic model of biological membranes. Add a labelled diagram.</div>
</div>
<div class="q-body">
<h2 class="section-title">Introduction</h2>
<p>The <strong>Fluid Mosaic Model</strong> was proposed by <strong>Singer and Nicolson (1972)</strong>. It describes the plasma membrane as a dynamic, two-dimensional fluid consisting of a phospholipid bilayer with proteins "floating" in it like a mosaic. The word "fluid" refers to the lateral mobility of phospholipids, and "mosaic" refers to the diverse protein components embedded within.</p>
<h2 class="section-title">Labelled Diagram</h2>
<div class="diagram">
<div class="diagram-title">🔬 Fluid Mosaic Model of Biological Membrane</div>
<pre style="font-size:10px; line-height:1.6; color:#1a1a2e; text-align:left; display:inline-block; width:100%;">
EXTRACELLULAR SPACE
←─── Glycocalyx (sugar coat) ─────────────────────────────────────────►
┌┐ ┌┐ ┌┐ ┌┐ ┌┐ ┌┐ ┌┐ ┌┐
~Y~ ││ ││ ││ ││ ││ ││ ││ ││ ← Glycoprotein/
││ ││ ││ ││ ││ ││ ││ ││ Glycolipid chains
┌───────┴┴─┴┴──┴┴──┴┴──────────────┴┴──┴┴─┴┴──┴┴────────────────────────┐
│ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ │
│░░░░PHOSPHOLIPID OUTER LEAFLET (Phosphatidylcholine, Sphingomyelin)░░░░░│
│ ┌────────────┐ ┌─────────────────────────────┐ ┌──────────────┐ │
│ │ Integral │ │ Peripheral Protein │ │ Cholesterol │ │
│ │ Protein │ │ (e.g. G-protein) │ │ molecule │ │
│────│────────────│──│─────────────────────────────│──│──────────────│───│
│ │ (Spans │ │ │ │ (regulates │ │
│ │ bilayer) │ │ Ion Channel │ │ fluidity) │ │
│░░░░│░░░░░░░░░░░░│░░│░░░░░░░░░░░░░░░░░░░░░░░░░░░░░│░░│░░░░░░░░░░░░░░│░░░│
│░░░░PHOSPHOLIPID INNER LEAFLET (PE, PS, PI - more negative charge)░░░░░│
│ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ ░ │
└───────────────────────────────────────────────────────────────────────┘
←─── Cytoskeletal anchor (Spectrin, Ankyrin) ──────────────────────────►
INTRACELLULAR SPACE (CYTOPLASM)
LEGEND:
░░ = Phospholipid bilayer ~Y~ = Receptor protein
Cholesterol: ▓ (fills gaps, reduces fluidity at high temp, prevents solidification at low temp)</pre>
</div>
<h2 class="section-title">Components of the Fluid Mosaic Model</h2>
<h3 class="sub-title">1. Phospholipid Bilayer</h3>
<ul>
<li><strong>Amphipathic molecules</strong>: hydrophilic polar head (faces water) + hydrophobic fatty acid tails (face interior)</li>
<li>Thickness: ~7-8 nm</li>
<li>Spontaneously forms bilayer in aqueous environment (thermodynamically favorable)</li>
<li><strong>Outer leaflet</strong>: Phosphatidylcholine (PC), Sphingomyelin, Glycolipids</li>
<li><strong>Inner leaflet</strong>: Phosphatidylethanolamine (PE), Phosphatidylserine (PS, negatively charged), Phosphatidylinositol (PI)</li>
<li><strong>Asymmetry</strong> maintained by flippases, floppases, and scramblases</li>
<li>PS exposure on outer leaflet signals apoptosis (recognized by macrophages)</li>
</ul>
<h3 class="sub-title">2. Cholesterol</h3>
<ul>
<li>Intercalates between phospholipids with OH group near polar head</li>
<li>Constitutes ~30-40% of membrane lipids in animal cells</li>
<li><strong>Dual role in fluidity</strong>: At high temp - reduces fluidity (prevents excessive motion); At low temp - prevents solidification (maintains fluidity)</li>
<li>Enriched in lipid rafts (specialized microdomains important for signaling)</li>
</ul>
<h3 class="sub-title">3. Membrane Proteins</h3>
<table>
<tr><th>Type</th><th>Description</th><th>Examples</th><th>Function</th></tr>
<tr>
<td><strong>Integral (Intrinsic) Proteins</strong></td>
<td>Embedded within the bilayer; transmembrane or monotopic; cannot be removed by mild treatment</td>
<td>Band 3 (anion exchanger), Na⁺/K⁺-ATPase, glucose transporters (GLUT), ion channels, GPCRs</td>
<td>Transport, receptors, enzymes, structural</td>
</tr>
<tr>
<td><strong>Peripheral (Extrinsic) Proteins</strong></td>
<td>Loosely attached to membrane surface via ionic/electrostatic interactions; removed by mild treatment (high salt)</td>
<td>Spectrin, Ankyrin (erythrocyte), G-protein subunits</td>
<td>Cytoskeletal anchoring, signaling, structural support</td>
</tr>
<tr>
<td><strong>Lipid-Anchored Proteins</strong></td>
<td>Covalently attached to lipid moiety in membrane; GPI-anchored on outer leaflet; farnesylated on inner leaflet</td>
<td>CD55, CD59 (outer); Ras, Src (inner)</td>
<td>Signaling, complement regulation</td>
</tr>
</table>
<h3 class="sub-title">4. Carbohydrates (Glycocalyx)</h3>
<ul>
<li>Oligosaccharide chains attached to lipids (glycolipids) or proteins (glycoproteins) on extracellular surface only</li>
<li>Functions: cell-cell recognition, blood group antigens (ABO), protection against proteolysis, cell adhesion, lubrication</li>
<li>Composition: sialic acid, galactose, fucose, mannose, GlcNAc</li>
</ul>
<h2 class="section-title">Fluid Characteristics of the Membrane</h2>
<div class="two-col">
<div class="col-box">
<h4>Lateral Diffusion (Fast)</h4>
<ul>
<li>Lipid molecules move laterally within same leaflet</li>
<li>Rate: ~10⁷ times/second</li>
<li>Responsible for "fluid" nature</li>
<li>Demonstrated by FRAP (Fluorescence Recovery After Photobleaching)</li>
</ul>
</div>
<div class="col-box">
<h4>Flip-Flop (Transverse) Diffusion (Rare)</h4>
<ul>
<li>Movement from one leaflet to other</li>
<li>Very rare and slow (t½ = days) for phospholipids without enzymes</li>
<li>Flippases (aminophospholipid translocase): move PE, PS to inner leaflet</li>
<li>Scramblases: randomize distribution during apoptosis/platelet activation</li>
</ul>
</div>
</div>
<h2 class="section-title">Factors Affecting Membrane Fluidity</h2>
<table>
<tr><th>Factor</th><th>Effect on Fluidity</th><th>Mechanism</th></tr>
<tr><td>Unsaturated fatty acids (more double bonds)</td><td>↑ Fluidity</td><td>Kinks prevent tight packing</td></tr>
<tr><td>Short-chain fatty acids</td><td>↑ Fluidity</td><td>Less van der Waals interactions</td></tr>
<tr><td>High temperature</td><td>↑ Fluidity</td><td>Increased kinetic energy</td></tr>
<tr><td>Cholesterol (at physiologic temp)</td><td>↓ Fluidity</td><td>Fills gaps, reduces phospholipid mobility</td></tr>
<tr><td>Cholesterol (at low temp)</td><td>↑ Fluidity</td><td>Prevents crystallization</td></tr>
<tr><td>Saturated fatty acids</td><td>↓ Fluidity</td><td>Tight packing due to straight chains</td></tr>
</table>
<div class="clinical-box">
<div class="box-title">Clinical Significance</div>
<ul>
<li><strong>PNH (Paroxysmal Nocturnal Hemoglobinuria):</strong> Deficiency of PIG-A gene → GPI-anchor synthesis defect → CD55, CD59 absent → complement-mediated hemolysis</li>
<li><strong>Anesthetic mechanism:</strong> Local anesthetics dissolve in membrane lipids, altering fluidity and channel function</li>
<li><strong>Atherosclerosis:</strong> Oxidized LDL disrupts membrane cholesterol homeostasis</li>
<li><strong>Hereditary Spherocytosis:</strong> Spectrin/Ankyrin defects → loss of membrane cytoskeletal support → spherocytes → hemolysis</li>
</ul>
</div>
</div>
</div>
<!-- ===================== QUESTION 4 ===================== -->
<div class="question-block">
<div class="q-header">
<div class="q-number">4</div>
<div class="q-title">Classify membrane transport mechanisms. Describe any two with examples.</div>
</div>
<div class="q-body">
<h2 class="section-title">Classification of Membrane Transport</h2>
<div class="diagram">
<div class="diagram-title">Classification Flowchart</div>
<div class="flowchart">
<div class="flow-box" style="min-width:400px;">MEMBRANE TRANSPORT</div>
<div class="flow-arrow">↓</div>
<div class="flow-row">
<div>
<div class="flow-box green">PASSIVE TRANSPORT<br/>(No energy needed; down conc. gradient)</div>
<div class="flow-arrow">↓</div>
<div class="flow-row">
<div style="text-align:center;">
<div class="flow-box" style="min-width:150px; font-size:11px;">Simple Diffusion</div>
<div style="font-size:10px; color:#555; margin:2px;">O₂, CO₂, H₂O, urea</div>
</div>
<div style="text-align:center;">
<div class="flow-box orange" style="min-width:150px; font-size:11px;">Facilitated Diffusion</div>
<div style="font-size:10px; color:#555; margin:2px;">GLUT1-5, Aquaporins</div>
</div>
<div style="text-align:center;">
<div class="flow-box purple" style="min-width:150px; font-size:11px;">Osmosis</div>
<div style="font-size:10px; color:#555; margin:2px;">Water across semipermeable membrane</div>
</div>
</div>
</div>
<div style="width:60px; text-align:center; font-size:30px; color:#0f3460;">|</div>
<div>
<div class="flow-box red">ACTIVE TRANSPORT<br/>(Energy needed; against gradient)</div>
<div class="flow-arrow">↓</div>
<div class="flow-row">
<div style="text-align:center;">
<div class="flow-box teal" style="min-width:150px; font-size:11px;">Primary Active<br/>(Direct ATP)</div>
<div style="font-size:10px; color:#555; margin:2px;">Na⁺/K⁺-ATPase, Ca²⁺-ATPase</div>
</div>
<div style="text-align:center;">
<div class="flow-box gold" style="min-width:150px; font-size:11px;">Secondary Active<br/>(Electrochemical gradient)</div>
<div style="font-size:10px; color:#555; margin:2px;">SGLT1, Na⁺/H⁺ exchanger</div>
</div>
</div>
</div>
</div>
<br/>
<div class="flow-box" style="min-width:400px;">VESICULAR TRANSPORT (Bulk Transport)</div>
<div class="flow-row">
<div class="flow-box green" style="min-width:150px; font-size:11px;">Endocytosis<br/>(Phagocytosis, Pinocytosis, Receptor-mediated)</div>
<div class="flow-box red" style="min-width:150px; font-size:11px;">Exocytosis<br/>(Constitutive & Regulated)</div>
<div class="flow-box purple" style="min-width:150px; font-size:11px;">Transcytosis<br/>(Across epithelial cells)</div>
</div>
</div>
</div>
<h2 class="section-title">Description of Two Transport Mechanisms</h2>
<h3 class="sub-title">1. Facilitated Diffusion</h3>
<p>Transport of substances <strong>down their concentration gradient</strong> (high → low) using specific membrane carrier proteins or channel proteins, <strong>without energy expenditure</strong>. Rate is faster than simple diffusion and shows saturation kinetics.</p>
<div class="two-col">
<div class="col-box">
<h4>Channel Proteins</h4>
<ul>
<li>Form water-filled pores</li>
<li>Ion channels: Na⁺, K⁺, Ca²⁺, Cl⁻ channels</li>
<li>Aquaporins: water-selective channels (AQP1-AQP13)</li>
<li>Gated: voltage-gated, ligand-gated, mechanically-gated</li>
<li>Very fast transport (millions of ions/sec)</li>
</ul>
</div>
<div class="col-box">
<h4>Carrier (Transporter) Proteins</h4>
<ul>
<li>Undergo conformational change</li>
<li>GLUT family (GLUT1-14): glucose transport</li>
<li>GLUT1: erythrocytes, brain (insulin-independent)</li>
<li>GLUT2: liver, pancreatic β-cells, kidney</li>
<li>GLUT4: muscle, adipose (insulin-dependent)</li>
<li>Slower than channels; saturable; specific</li>
</ul>
</div>
</div>
<div class="clinical-box">
<div class="box-title">Clinical Significance of Facilitated Diffusion</div>
<ul>
<li><strong>GLUT2 in β-cells:</strong> High Km glucose transporter acts as glucose sensor; drives insulin secretion at high blood glucose</li>
<li><strong>GLUT4 & Insulin:</strong> Insulin triggers GLUT4 vesicle translocation to plasma membrane → increased glucose uptake in muscle/fat. Defect → Type 2 DM</li>
<li><strong>Aquaporin-2 & ADH:</strong> ADH inserts AQP2 into collecting duct → water reabsorption. Defect → Nephrogenic Diabetes Insipidus</li>
<li><strong>Cystic Fibrosis:</strong> CFTR (Cl⁻ channel) mutation → defective Cl⁻ transport → thick mucus secretions</li>
</ul>
</div>
<h3 class="sub-title">2. Primary Active Transport — Na⁺/K⁺-ATPase Pump</h3>
<p>Uses ATP directly to transport substances <strong>against their electrochemical gradients</strong>. The Na⁺/K⁺-ATPase (sodium pump) is the prototype and most important primary active transporter in animals.</p>
<div class="diagram">
<div class="diagram-title">Na⁺/K⁺-ATPase Pump Mechanism</div>
<pre style="font-size:10px; line-height:1.6; color:#1a1a2e; text-align:left; display:inline-block;">
EXTRACELLULAR (high Na⁺ outside, high K⁺ inside)
←─────────────────── 2 K⁺ IN ──────────────────────
┌───────────────────────────────────────────────────┐
│ PLASMA MEMBRANE │
│ │
│ [E1-ATP] ──ATP→ [E1-P] ─→ [E2-P] ─→ [E2] ─→ │
│ binds 3Na⁺ phospho- releases releases │
│ intracellular enzyme 3Na⁺ 2K⁺ │
│ conformation extracell intracell │
└───────────────────────────────────────────────────┘
──────────────────── 3 Na⁺ OUT ─────────────────────►
INTRACELLULAR
Net: 3Na⁺ OUT, 2K⁺ IN, 1 ATP consumed
Creates: negative intracellular potential, osmotic balance</pre>
</div>
<h4 style="color:#0f3460; margin:10px 0 6px 0;">Properties of Na⁺/K⁺-ATPase:</h4>
<ul>
<li>Structure: αβ-heterodimer; α-subunit is catalytic; β-subunit is structural/regulatory</li>
<li>Pumps 3 Na⁺ out and 2 K⁺ in per ATP hydrolyzed - electrogenic (creates net negative charge inside)</li>
<li>Maintains resting membrane potential (-70 mV in nerve cells)</li>
<li>Accounts for ~30% of total body ATP consumption (60-70% in neurons)</li>
<li>Drives secondary active transport via Na⁺ gradient</li>
</ul>
<table>
<tr><th>Function</th><th>Mechanism</th><th>Clinical Relevance</th></tr>
<tr><td>Cell volume regulation</td><td>Controls intracellular osmolarity by regulating Na⁺, K⁺</td><td>Cell swelling in ischemia when pump fails</td></tr>
<tr><td>Nerve impulse propagation</td><td>Restores resting potential after action potential</td><td>Local anesthetics block Na⁺ channels</td></tr>
<tr><td>Muscle contraction</td><td>Maintains K⁺ gradient needed for repolarization</td><td>Hypokalemia → arrhythmias</td></tr>
<tr><td>Renal Na⁺ reabsorption</td><td>Creates driving force for SGLT in proximal tubule</td><td>Diuretics target Na⁺ transport</td></tr>
<tr><td>Cardiac function</td><td>Regulates cardiac contractility</td><td>Digoxin inhibits pump → ↑ intracellular Ca²⁺ → positive inotropy</td></tr>
</table>
<div class="warning-box">
<div class="box-title">Secondary Active Transport (Cotransport)</div>
<p>Uses the Na⁺ electrochemical gradient (created by Na⁺/K⁺-ATPase) to drive uphill transport of other solutes:<br/>
<strong>Symport (same direction):</strong> SGLT1/2 - Na⁺ + glucose (gut & kidney); Na⁺/amino acid cotransporters<br/>
<strong>Antiport (opposite direction):</strong> Na⁺/H⁺ exchanger (NHE) - important in acid-base balance; Na⁺/Ca²⁺ exchanger<br/>
<strong>Clinical:</strong> SGLT2 inhibitors (Empagliflozin, Dapagliflozin) block renal glucose reabsorption → glucosuria → lower blood glucose; used in Type 2 DM</p>
</div>
</div>
</div>
<!-- ===================== QUESTION 5 ===================== -->
<div class="question-block">
<div class="q-header">
<div class="q-number">5</div>
<div class="q-title">Define carbohydrates. Classify with suitable examples. Add a note on glycosaminoglycans.</div>
</div>
<div class="q-body">
<h2 class="section-title">Definition of Carbohydrates</h2>
<p>Carbohydrates are polyhydroxy aldehydes or polyhydroxy ketones, or compounds that yield these on hydrolysis. The empirical formula is <strong>Cₙ(H₂O)ₙ</strong>, though this does not hold for all carbohydrates (e.g., deoxyribose C₅H₁₀O₄, rhamnose). They are the most abundant biomolecules on Earth and the primary source of energy (4 kcal/g).</p>
<h2 class="section-title">Classification of Carbohydrates</h2>
<div class="flowchart" style="text-align:center;">
<div class="flow-box" style="min-width:500px;">CARBOHYDRATES</div>
<div class="flow-arrow">↓</div>
<div class="flow-row">
<div style="text-align:center;">
<div class="flow-box green">MONOSACCHARIDES<br/>(Cannot be hydrolyzed)</div>
<br/>
<div class="flow-box" style="min-width:180px; font-size:10px;">Trioses (C3): Glyceraldehyde</div>
<div class="flow-box orange" style="min-width:180px; font-size:10px;">Tetroses (C4): Erythrose</div>
<div class="flow-box purple" style="min-width:180px; font-size:10px;">Pentoses (C5): Ribose, Xylose</div>
<div class="flow-box teal" style="min-width:180px; font-size:10px;">Hexoses (C6): Glucose, Fructose, Galactose, Mannose</div>
<div class="flow-box red" style="min-width:180px; font-size:10px;">Heptoses (C7): Sedoheptulose</div>
</div>
<div style="width:40px;"></div>
<div style="text-align:center;">
<div class="flow-box orange">OLIGOSACCHARIDES<br/>(2-10 monosaccharide units)</div>
<br/>
<div class="flow-box" style="min-width:180px; font-size:10px;">Disaccharides:<br/>Sucrose (Glc+Fru)<br/>Lactose (Gal+Glc)<br/>Maltose (Glc+Glc)<br/>Cellobiose (Glc+Glc, β)<br/>Trehalose (Glc+Glc, α,α)</div>
<div class="flow-box green" style="min-width:180px; font-size:10px; margin-top:10px;">Trisaccharides:<br/>Raffinose, Melezitose</div>
</div>
<div style="width:40px;"></div>
<div style="text-align:center;">
<div class="flow-box purple">POLYSACCHARIDES<br/>(>10 monosaccharide units)</div>
<br/>
<div class="flow-box" style="min-width:180px; font-size:10px;">Homopolysaccharides:<br/>Starch (amylose+amylopectin)<br/>Glycogen (animal starch)<br/>Cellulose (β-1,4 linkages)<br/>Chitin (GlcNAc polymer)<br/>Inulin (fructose polymer)</div>
<div class="flow-box teal" style="min-width:180px; font-size:10px; margin-top:10px;">Heteropolysaccharides:<br/>Glycosaminoglycans (GAGs)<br/>Proteoglycans<br/>Hyaluronic acid<br/>Blood group substances</div>
</div>
</div>
</div>
<h3 class="sub-title">Important Monosaccharides</h3>
<table>
<tr><th>Monosaccharide</th><th>Type</th><th>Key Features / Occurrence</th></tr>
<tr><td><strong>D-Glucose</strong></td><td>Aldohexose</td><td>Most important energy source; blood sugar (70-100 mg/dL fasting); Haworth formula forms α and β anomers in pyranose ring</td></tr>
<tr><td><strong>D-Fructose</strong></td><td>Ketohexose</td><td>Sweetest sugar; fruits, honey; enters glycolysis via fructose-1-phosphate pathway; does not require insulin for uptake in liver</td></tr>
<tr><td><strong>D-Galactose</strong></td><td>Aldohexose</td><td>Epimer of glucose at C4; component of lactose, cerebrosides, gangliosides; metabolized via Leloir pathway (galactokinase)</td></tr>
<tr><td><strong>D-Ribose</strong></td><td>Aldopentose</td><td>Backbone of RNA; component of ATP, NAD, FAD, CoA</td></tr>
<tr><td><strong>2-Deoxyribose</strong></td><td>Modified aldopentose</td><td>Backbone of DNA; H replaces OH at C2</td></tr>
<tr><td><strong>D-Mannose</strong></td><td>Aldohexose</td><td>Component of glycoproteins (mannose-6-phosphate tag for lysosomal targeting)</td></tr>
</table>
<h3 class="sub-title">Medically Important Disaccharides</h3>
<table>
<tr><th>Disaccharide</th><th>Composition</th><th>Linkage</th><th>Enzyme</th><th>Clinical Note</th></tr>
<tr><td><strong>Sucrose</strong></td><td>Glucose + Fructose</td><td>α1-β2 glycosidic</td><td>Sucrase</td><td>Table sugar; not reducing (no free anomeric C)</td></tr>
<tr><td><strong>Lactose</strong></td><td>Galactose + Glucose</td><td>β1-4 glycosidic</td><td>Lactase</td><td>Milk sugar; reducing sugar; lactase deficiency → osmotic diarrhea</td></tr>
<tr><td><strong>Maltose</strong></td><td>Glucose + Glucose</td><td>α1-4 glycosidic</td><td>Maltase</td><td>Product of starch digestion; found in malt beverages</td></tr>
<tr><td><strong>Isomaltose</strong></td><td>Glucose + Glucose</td><td>α1-6 glycosidic</td><td>Isomaltase</td><td>From branch points of starch; reducing sugar</td></tr>
</table>
<h2 class="section-title">Note on Glycosaminoglycans (GAGs)</h2>
<p>Glycosaminoglycans (formerly mucopolysaccharides) are long, unbranched heteropolysaccharides composed of repeating disaccharide units. They consist of an amino sugar (glucosamine or galactosamine) and a uronic acid (glucuronic or iduronic acid) or galactose. They are highly negatively charged due to sulfate and carboxylate groups, which attract water molecules.</p>
<h3 class="sub-title">Classification of GAGs</h3>
<table>
<tr><th>GAG</th><th>Repeating Unit</th><th>Sulfation</th><th>Location</th><th>Function</th></tr>
<tr><td><strong>Hyaluronic Acid</strong></td><td>GlcA + GlcNAc</td><td>None (not sulfated)</td><td>Synovial fluid, vitreous humor, cartilage, umbilical cord</td><td>Lubrication, hydration, shock absorption, wound healing</td></tr>
<tr><td><strong>Chondroitin Sulfate</strong></td><td>GlcA + GalNAc-SO₄</td><td>4-SO₄ or 6-SO₄</td><td>Cartilage, bone, tendons, aorta</td><td>Structural support; most abundant GAG in body</td></tr>
<tr><td><strong>Dermatan Sulfate</strong></td><td>IdoA + GalNAc-SO₄</td><td>4-SO₄</td><td>Skin, blood vessels, heart valves</td><td>Wound healing, coagulation, vascular biology</td></tr>
<tr><td><strong>Heparan Sulfate</strong></td><td>GlcA/IdoA + GlcNAc</td><td>Variable, high degree</td><td>Basement membranes, cell surfaces</td><td>Cell signaling, angiogenesis, antithrombin binding</td></tr>
<tr><td><strong>Heparin</strong></td><td>IdoA-2-SO₄ + GlcNS-6-SO₄</td><td>Highest degree (most negative)</td><td>Mast cells, basophils</td><td>Anticoagulant (binds antithrombin III); medical use as anticoagulant</td></tr>
<tr><td><strong>Keratan Sulfate</strong></td><td>Gal + GlcNAc-6-SO₄</td><td>6-SO₄</td><td>Cornea, cartilage, bone</td><td>No uronic acid (unique); corneal transparency</td></tr>
</table>
<h3 class="sub-title">Structure & Properties of GAGs</h3>
<ul>
<li>Exist as <strong>proteoglycans</strong>: GAG chains covalently attached to core protein (serine residues)</li>
<li>Highly hydrophilic - attract large volumes of water → gel-like extracellular matrix</li>
<li>Negative charges repel each other → resist compression (important in cartilage)</li>
<li>Except heparin (stored in mast cell granules), all are extracellular matrix components</li>
</ul>
<div class="clinical-box">
<div class="box-title">Clinical Significance of GAGs</div>
<ul>
<li><strong>Mucopolysaccharidoses (MPS):</strong> Inherited deficiency of GAG-degrading lysosomal enzymes → accumulation of GAGs → storage disease (Hurler, Hunter, Morquio syndromes)</li>
<li><strong>Heparin therapy:</strong> Anticoagulant effect by binding antithrombin III → accelerates its inactivation of thrombin and Factor Xa by 1000-fold</li>
<li><strong>Osteoarthritis:</strong> Loss of proteoglycans from articular cartilage → loss of water → cartilage degeneration</li>
<li><strong>Corneal transplant preservation:</strong> Chondroitin sulfate used to maintain corneal transparency</li>
<li><strong>Hyaluronic acid injections:</strong> Used in knee osteoarthritis, cosmetic fillers</li>
</ul>
</div>
</div>
</div>
'''
with open('/home/daytona/workspace/biochem-notes/part1.html', 'w', encoding='utf-8') as f:
f.write(content)
print("Part 1 written successfully:", len(content), "characters")
Running Command
cd /home/daytona/workspace/biochem-notes && python generate_part1.py
This is a shared conversation. Sign in to Orris to start your own chat.